News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.
Isogenica’s
Latest News
Isogenica expands collaboration with Aro Biotherapeutics
Isogenica today announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics in June 2018.Under the expanded agreement, Isogenica will use its CIS Display...
Isogenica appoints Dr Emma Sceats as Chief Executive Officer
Isogenica Ltd, a leader in the design and construction of diverse, fully synthetic, antibody libraries for biopharmaceutical discovery, today announced that Dr Emma Sceats has been appointed Chief...
Isogenica licenses CIS Display Technology
Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia. USA, that will leverage each other’s strengths in recombinant...
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.
Events
Resources
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
Review: The Application of Nanobody in CAR-T Therapy
Bao et al review the intersection between CAR-T development and VHHs against over a dozen tumour-associated antigens, with a focus on the bi-specific VHH therapy LCAR-B38M, now approved as CARVYKTI™.
VHHs enable multi-specific targeting for Tandem-CAR therapies
In this poster from 7th CAR-TCR Summit in Boston, we discuss the power of VHHs in creating multi-specific ectodomains.
Webinars
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Isogenica’s
Newsletters
Catch up with Isogenica’s news and activies through the latest Newsletters.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.